← Every company
Guardant Health Inc Lobbying
What Guardant Health Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
GH on carbonthat →Disclosed spend
$613K
across every filing on file
Filings
7
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesMedicare/MedicaidMedical/Disease Research/Clinical Labs
7 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | GUARDANT HEALTHMedicare/MedicaidHealth Issues | $241K |
| 20262nd Quarter (Apr 1 - June 30) | GUARDANT HEALTHMedicare/MedicaidHealth Issues | $180K |
| 20262nd Quarter (Apr 1 - June 30) | TODD STRATEGY GROUPHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | IPOLICY SOLUTIONSMedicare/Medicaid | $16K |
| 20261st Quarter (Jan 1 - Mar 31) | IPOLICY SOLUTIONSMedicare/MedicaidMedical/Disease Research/Clinical Labs | $16K |
| 20261st Quarter (Jan 1 - Mar 31) | DC STRATEGISTS LLC | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on GH
Company overviewEverything on GH in one place, with the price.SEC filingsWhat GH's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat GH's own officers and directors buy and sell.Planned salesSales GH insiders have filed notice of.Who owns itEvery manager reporting a position in GH.Funds holding itWhich funds and ETFs hold GH, and how big a bet.Who lobbies for itThe lobbyists on GH's account, and who they worked for.PatentsWhat GH is filing at the patent office.